Scolaris Content Display Scolaris Content Display

Drenaje abdominal para la prevención del absceso intraperitoneal después de una apendicectomía abierta por una apendicitis complicada

This is not the most recent version

Appendices

Appendix 1. Search strategy for CENTRAL (2017, Issue 6)

#1 MeSH descriptor: [Appendectomy] explode all trees

#2 MeSH descriptor: [Appendicitis] explode all trees

#3 appendectom* or appendic*:ti,ab,kw

#4 (#1 or #2 or #3)

#5 MeSH descriptor: [Drainage] explode all trees

#6 MeSH descriptor: [Suction] explode all trees

#7 MeSH descriptor: [Negative‐Pressure Wound Therapy] explode all trees

#8 ((negative pressure or negative‐pressure) near/3 (dressing* or therap*)):ti,ab,kw

#9 ((vacuum‐assisted or vacuum assisted) near/3 closure*):ti,ab,kw

#10 (drain* or suction*):ti,ab,kw

#11 (#5 or #6 or #7 or #8 or #9 or #10)

#12 (#4 and #11)

Appendix 2. Search strategy for MEDLINE (Ovid) (1946 to 30 June 2017)

1. exp Appendectomy/

2. exp Appendicitis/

3. (appendectom* or appendic*).mp.

4. 1 or 2 or 3

5. exp Drainage/

6. exp Negative‐Pressure Wound Therapy/

7. exp Suction/

8. ((negative pressure or negative‐pressure) adj3 (dressing* or therap*)).mp.

9. ((vacuum‐assisted or vacuum assisted) adj closure*).mp.

10. (drain* or suction*).mp.

11. 5 or 6 or 7 or 8 or 9 or 10

12. 4 and 11

13. randomized controlled trial.pt.

14. controlled clinical trial.pt.

15. randomized.ab.

16. placebo.ab.

17. clinical trials as topic.sh.

18. randomly.ab.

19. trial.ti.

20. 13 or 14 or 15 or 16 or 17 or 18 or 19

21. exp animals/ not humans.sh.

22. 20 not 21

23. 12 and 22

Appendix 3. Search strategy for Embase (Ovid) (1974 to 30 June 2017)

1. exp appendectomy/

2. exp acute appendicitis/

3. exp appendicitis/

4. (appendectom* or appendic*).mp.

5. 1 or 2 or 3 or 4

6. exp drain/

7. exp abscess drainage/

8. exp abdominal drainage/

9. exp wound drainage/

10. exp surgical drainage/

11. exp vacuum assisted closure/

12. exp suction/

13. ((negative pressure or negative‐pressure) adj3 (dressing* or therap*)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

14. ((vacuum‐assisted or vacuum assisted) adj closure*).mp.

15. (drain* or suction*).mp.

16. 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15

17. 5 and 16

18. CROSSOVER PROCEDURE.sh.

19. DOUBLE‐BLIND PROCEDURE.sh.

20. SINGLE‐BLIND PROCEDURE.sh.

21. (crossover* or cross over*).ti,ab.

22. placebo*.ti,ab.

23. (doubl* adj blind*).ti,ab.

24. allocat*.ti,ab.

25. trial.ti.

26. RANDOMIZED CONTROLLED TRIAL.sh.

27. random*.ti,ab.

28. 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27

29. (exp animal/ or exp invertebrate/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans or man or men or wom?n).ti.)

30. 28 not 29

31. 17 and 30

Appendix 4. Search strategy for Science Citation Index Expanded (1900 to 30 June 2017)

#1 Topic=(appendectom* OR appendic*)

#2 Topic=(drain* OR suction* OR negative pressure wound therap* OR negative‐pressure wound therap* OR vacuum‐assisted closure OR vacuum assisted closure*)

#3 Topic=(random* OR control* OR RCT* OR placebo OR trial* OR group*)

#4 (#1 AND #2 AND #3)

Appendix 5. Criteria for judging risk of bias in the 'Risk of bias' assessment tool

Random sequence generation

Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence.

Criteria for a judgement of 'Low risk' of bias.

The investigators described a random component in the sequence generation process such as:

  • referring to a random number table;

  • using a computer random number generator;

  • coin tossing;

  • shuffling cards or envelopes;

  • throwing dice;

  • drawing of lots;

  • minimisation.*

*Minimisation may be implemented without a random element, and this is considered to be equivalent to being random.

Criteria for the judgement of 'High risk' of bias.

The investigators described a non‐random component in the sequence generation process. Usually, the description would involve some systematic, non‐random approach, e.g.:

  • sequence generated by odd or even date of birth;

  • sequence generated by some rule based on date (or day) of admission;

  • sequence generated by some rule based on hospital or clinic record number.

Other non‐random approaches happen much less frequently than the systematic approaches mentioned above and tend to be obvious. They usually involve judgement or some method of non‐random categorisation of participants, e.g.:

  • allocation by judgement of the clinician;

  • allocation by preference of the participant;

  • allocation based on the results of a laboratory test or a series of tests;

  • allocation by availability of the intervention.

Criteria for the judgement of 'Unclear risk' of bias.

Insufficient information about the sequence generation process to permit judgement of 'Low risk' or 'High risk.'

Allocation concealment

Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment.

Criteria for a judgement of 'Low risk' of bias.

Participants and investigators enrolling participants could not have foreseen assignment because one of the following, or an equivalent method, was used to conceal allocation:

  • central allocation (including telephone, web‐based and pharmacy‐controlled randomisation);

  • sequentially numbered drug containers of identical appearance;

  • sequentially numbered, opaque, sealed envelopes.

Criteria for the judgement of 'High risk' of bias.

Participants or investigators enrolling participants could possibly have foreseen assignments and thus introduced selection bias, such as allocation based on:

  • using an open random allocation schedule (e.g. a list of random numbers);

  • assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non­opaque or not sequentially numbered);

  • alternation or rotation;

  • date of birth;

  • case record number;

  • any other explicitly unconcealed procedure.

Criteria for the judgement of 'Unclear risk' of bias.

Insufficient information to permit judgement of 'Low risk' or 'High risk.' This is usually the case if the method of concealment was not described or not described in sufficient detail to allow a definite judgement; e.g. if the use of assignment envelopes was described, but it remained unclear whether envelopes were sequentially numbered, opaque and sealed.

Blinding of participants and personnel

Performance bias due to knowledge of the allocated interventions by participants and personnel during the study.

Criteria for a judgement of 'Low risk' of bias.

Any one of the following:

  • no blinding or incomplete blinding, but the review authors judged that the outcome was not likely to be influenced by lack of blinding;

  • blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.

Criteria for the judgement of 'High risk' of bias.

Any one of the following:

  • no blinding or incomplete blinding, and the outcome was likely to be influenced by lack of blinding;

  • blinding of key study participants and personnel attempted, but likely that the blinding could have been broken, and the outcome was likely to be influenced by lack of blinding.

Criteria for the judgement of 'Unclear risk' of bias.

Any one of the following:

  • insufficient information to permit judgement of 'Low risk' or 'High risk;'

  • study did not address this outcome.

Blinding of outcome assessment

Detection bias due to knowledge of the allocated interventions by outcome assessors.

Criteria for a judgement of 'Low risk' of bias.

Any one of the following:

  • no blinding of outcome assessment, but the review authors judged that the outcome measurement was not likely to be influenced by lack of blinding;

  • blinding of outcome assessment ensured, and unlikely that the blinding could have been broken.

Criteria for the judgement of 'High risk' of bias.

Any one of the following:

  • no blinding of outcome assessment, and the outcome measurement was likely to be influenced by lack of blinding;

  • blinding of outcome assessment, but likely that the blinding could have been broken, and the outcome measurement was likely to be influenced by lack of blinding.

Criteria for the judgement of 'Unclear risk' of bias.

Any one of the following:

  • insufficient information to permit judgement of 'Low risk' or 'High risk;'

  • study did not address this outcome.

Incomplete outcome data

Attrition bias due to amount, nature, or handling of incomplete outcome data.

Criteria for a judgement of 'Low risk' of bias.

Any one of the following:

  • no missing outcome data;

  • reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias);

  • missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups;

  • for dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate;

  • for continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size;

  • missing data were imputed using appropriate methods.

Criteria for the judgement of 'High risk' of bias.

Any one of the following:

  • reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups;

  • for dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate;

  • for continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size;

  • 'as‐treated' analysis done with substantial departure of the intervention received from that assigned at randomisation;

  • potentially inappropriate application of simple imputation.

Criteria for the judgement of 'Unclear risk' of bias.

Any one of the following:

  • insufficient reporting of attrition/exclusions to permit judgement of 'Low risk' or 'High risk' (e.g. number randomised not stated, no reasons for missing data provided);

  • study did not address this outcome.

Selective reporting

Reporting bias due to selective outcome reporting.

Criteria for a judgement of 'Low risk' of bias.

Any of the following:

  • study protocol was available and all of the study's prespecified (primary and secondary) outcomes that were of interest in the review were reported in the prespecified way;

  • study protocol was not available but it was clear that the published reports included all expected outcomes, including those that were prespecified (convincing text of this nature may be uncommon).

Criteria for the judgement of 'High risk' of bias.

Any one of the following:

  • not all of the study's prespecified primary outcomes were reported;

  • ≥ 1 primary outcomes were reported using measurements, analysis methods, or subsets of data (e.g. subscales) that were not prespecified;

  • ≥ 1 reported primary outcomes were not prespecified (unless clear justification for their reporting was provided, such as an unexpected adverse effect);

  • ≥ 1 outcomes of interest in the review were reported incompletely so that they could not be entered in a meta‐analysis;

  • study report did not include results for a key outcome that would be expected to have been reported for such a study.

Criteria for the judgement of 'Unclear risk' of bias.

Insufficient information to permit judgement of 'Low risk' or 'High risk.' It is likely that the majority of studies will fall into this category.

Other bias

Bias due to problems not covered elsewhere in the table.

Criteria for a judgement of 'Low risk' of bias.

Study appeared to be free of other sources of bias.

Criteria for the judgement of 'High risk' of bias.

There was ≥ 1 important risk of bias; e.g. the study:

  • had a potential source of bias related to the specific study design used; or

  • was claimed to have been fraudulent; or

  • had some other problem.

Criteria for the judgement of 'Unclear risk' of bias.

There may be a risk of bias, but there was either:

  • insufficient information to assess whether an important risk of bias existed; or

  • insufficient rationale or evidence that an identified problem would introduce bias.

Study flow diagram.
Figures and Tables -
Figure 1

Study flow diagram.

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figures and Tables -
Figure 2

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
Figures and Tables -
Figure 3

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Trial sequential analysis of drain use versus no drain use for intra‐peritoneal abscess. Analysis was performed with an event rate of 10.7% (Pc) in the control group, a risk ratio reduction of 20%, alpha 5%, beta 20%, and observed diversity 63%. The cumulative Z‐curve did not cross the trial sequential boundaries (inward sloping etched lines). The results showed that the observed diversity‐adjusted required information size was 2,570 participants, corresponding to 20.3% of the total sample size in the included trials. Accordingly, the meta‐analysis did not support or refute an intervention effect as data were too few.
Figures and Tables -
Figure 4

Trial sequential analysis of drain use versus no drain use for intra‐peritoneal abscess. Analysis was performed with an event rate of 10.7% (Pc) in the control group, a risk ratio reduction of 20%, alpha 5%, beta 20%, and observed diversity 63%. The cumulative Z‐curve did not cross the trial sequential boundaries (inward sloping etched lines). The results showed that the observed diversity‐adjusted required information size was 2,570 participants, corresponding to 20.3% of the total sample size in the included trials. Accordingly, the meta‐analysis did not support or refute an intervention effect as data were too few.

Comparison 1 Drain use versus no drain use, Outcome 1 Intra‐peritoneal abscess.
Figures and Tables -
Analysis 1.1

Comparison 1 Drain use versus no drain use, Outcome 1 Intra‐peritoneal abscess.

Comparison 1 Drain use versus no drain use, Outcome 2 Wound infection.
Figures and Tables -
Analysis 1.2

Comparison 1 Drain use versus no drain use, Outcome 2 Wound infection.

Comparison 1 Drain use versus no drain use, Outcome 3 Morbidity.
Figures and Tables -
Analysis 1.3

Comparison 1 Drain use versus no drain use, Outcome 3 Morbidity.

Comparison 1 Drain use versus no drain use, Outcome 4 Mortality.
Figures and Tables -
Analysis 1.4

Comparison 1 Drain use versus no drain use, Outcome 4 Mortality.

Comparison 1 Drain use versus no drain use, Outcome 5 Hospital stay.
Figures and Tables -
Analysis 1.5

Comparison 1 Drain use versus no drain use, Outcome 5 Hospital stay.

Comparison 2 Drain use versus no drain use (sensitivity analyses by excluding quasi‐randomised trials), Outcome 1 Intra‐peritoneal abscess.
Figures and Tables -
Analysis 2.1

Comparison 2 Drain use versus no drain use (sensitivity analyses by excluding quasi‐randomised trials), Outcome 1 Intra‐peritoneal abscess.

Summary of findings for the main comparison. Drainage compared to no drainage for complicated appendicitis

Abdominal drainage to prevent intra‐peritoneal abscess after open appendectomy for complicated appendicitis

Patient or population: people undergoing emergency open appendectomy for complicated appendicitis
Setting: hospital
Intervention: drainage
Comparison: no drainage

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Risk with no drain use

Risk with drain use

Intra‐peritoneal abscess

Follow‐up: 14 days

107 per 1000

131 per 1000
(50 to 342)

RR 1.23
(0.47 to 3.21)

453
(5 studies)

⊕⊝⊝⊝
Very lowa,b,c

Wound infection

Follow‐up: 30 days

254 per 1000

511 per 1000
(224 to 1000)

RR 2.01
(0.88 to 4.56)

478
(5 studies)

⊕⊝⊝⊝
Very lowa,b,c

Morbidity

Follow‐up: 30 days

67 per 1000

445 per 1000
(142 to 1000)

RR 6.67
(2.13 to 20.87)

90
(1 study)

⊕⊝⊝⊝
Very lowa,c

Mortality

Follow‐up: 30 days month

6 per 1000

27 per 1000
(7 to 101)

Peto OR 4.88
(1.18 to 20.09)

363
(4 studies)

⊕⊕⊕⊝
Moderatec

Hospital stay (days)

The mean hospital stay in the control groups was 4.60 days

The mean hospital stay in the intervention groups was
2.17 days higher
(1.76 days to 2.58 days higher)

MD 2.17 days higher
(1.76 higher to 2.58 higher)

298
(3 studies)

⊕⊝⊝⊝
Very lowa,d

Hospital cost

Not reported

Pain

Not reported

Quality of life

Not reported

*The basis for the assumed risk is the mean comparison group proportion in the studies. The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; Peto OR: Peto odds ratio; RR: risk ratio

GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

a Downgraded two levels for very serious risk of bias.

b Downgraded one level for severe inconsistency (substantial heterogeneity as indicated by the I2 statistic).

c Downgraded one level for serious imprecision. For abscess, morbidity and infection, the confidence interval includes appreciable benefit and harm, and the sample size is small. For mortality, there are few events (8 deaths in total)

d Downgraded one level for serious imprecision (small sample size).

Figures and Tables -
Summary of findings for the main comparison. Drainage compared to no drainage for complicated appendicitis
Comparison 1. Drain use versus no drain use

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Intra‐peritoneal abscess Show forest plot

5

453

Risk Ratio (M‐H, Random, 95% CI)

1.23 [0.47, 3.21]

2 Wound infection Show forest plot

5

478

Risk Ratio (M‐H, Random, 95% CI)

2.01 [0.88, 4.56]

3 Morbidity Show forest plot

1

90

Risk Ratio (M‐H, Random, 95% CI)

6.67 [2.13, 20.87]

4 Mortality Show forest plot

4

363

Peto Odds Ratio (Peto, Fixed, 95% CI)

4.88 [1.18, 20.09]

5 Hospital stay Show forest plot

3

298

Mean Difference (IV, Random, 95% CI)

2.17 [1.76, 2.58]

Figures and Tables -
Comparison 1. Drain use versus no drain use
Comparison 2. Drain use versus no drain use (sensitivity analyses by excluding quasi‐randomised trials)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Intra‐peritoneal abscess Show forest plot

3

316

Risk Ratio (M‐H, Random, 95% CI)

0.76 [0.28, 2.02]

Figures and Tables -
Comparison 2. Drain use versus no drain use (sensitivity analyses by excluding quasi‐randomised trials)